Design and Feasibility of a Randomized Behavioral Intervention to Reduce Distributive Injection Risk and Improve Health-Care Access Among hepatitisC virus Positive Injection Drug Users: The Study to Reduce Intravenous Exposures (STRIVE)
Open Access
- 3 January 2007
- journal article
- research article
- Published by Springer Nature in Journal of Urban Health
- Vol. 84 (1), 99-115
- https://doi.org/10.1007/s11524-006-9133-7
Abstract
Hepatitis C virus (HCV) is hyperendemic among injection drug users (IDUs). However, few scientifically proven interventions to prevent secondary transmission of HCV from infected IDUs to others exist. This report describes the design, feasibility, and baseline characteristics of participants enrolled in the Study to Reduce Intravenous Exposure (STRIVE). STRIVE was a multisite, randomized-control trial to test a behavioral intervention developed to reduce distribution of used injection equipment (needles, cookers, cottons, and rinse water) and increase health-care utilization among antibody HCV (anti-HCV) positive IDUs. STRIVE enrolled anti-HCV positive IDU in Baltimore, New York City, and Seattle; participants completed behavioral assessments and venipuncture for HIV, HCV-RNA, and liver function tests (LFTs) and were randomized to attend either a six-session, small-group, peer-mentoring intervention workshop or a time-matched, attention-control condition. Follow-up visits were conducted at 3 and 6 months. At baseline, of the 630 HCV-positive IDUs enrolled (mean age of 26 years, 60% white, 76% male), 55% reported distributive needle sharing, whereas 74, 69, and 69% reported sharing cookers, cottons, and rinse water, respectively. Health-care access was low, with 41% reporting an emergency room as their main source of medical care. Among those enrolled, 66% (418/630) were randomized: 53% (222/418) and 47% (196/418) to the intervention and control conditions, respectively. Follow-up rates were 70 and 73% for the 3- and 6-month visits, respectively. As distributive sharing of used injection equipment was common while reports of receiving HCV care were low, these findings indicate an urgent need for HCV-related interventions with IDUs and demonstrate the acceptability and feasibility to do so.Keywords
This publication has 34 references indexed in Scilit:
- Eligibility for Treatment of Hepatitis C Virus Infection among Young Injection Drug Users in 3 US CitiesClinical Infectious Diseases, 2006
- Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: The HEP-NET acute-HCV-II studyHepatology, 2006
- The impact of injecting drug use status on hepatitis C-related referral and treatmentDrug and Alcohol Dependence, 2005
- Correlates of Hepatitis C virus infection in homeless men: a latent variable approachDrug and Alcohol Dependence, 2004
- A comparison of HCV antibody testing in drug-free and methadone maintenance treatment programs in the United StatesDrug and Alcohol Dependence, 2004
- Prevalence of human immunodeficiency virus, hepatitis b, and hepatitis c among homeless persons with co-occurring severe mental illness and substance use disordersComprehensive Psychiatry, 2003
- Lack of Behavior Change after Disclosure of Hepatitis C Virus Infection among Young Injection Drug Users in Baltimore, MarylandClinical Infectious Diseases, 2002
- Treatment of Acute Hepatitis C with Interferon Alfa-2bNew England Journal of Medicine, 2001
- HEPATITIS CInfectious Disease Clinics of North America, 1998
- Methadone maintenance and hepatitis C virus infection among injecting drug usersAddiction, 1997